-
1
-
-
5344263788
-
The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients
-
Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 2004; 40: 2293-2306.
-
(2004)
Eur J Cancer
, vol.40
, pp. 2293-2306
-
-
Ludwig, H.1
Van Belle, S.2
Barrett-Lee, P.3
-
2
-
-
0031741680
-
Frequency and significance of anemia in non-Hodgkin's lymphoma patients
-
Moullet I, Salles G, Ketterer N, et al. Frequency and significance of anemia in non-Hodgkin's lymphoma patients. Ann Oncol 1998; 9: 1109-1115.
-
(1998)
Ann Oncol
, vol.9
, pp. 1109-1115
-
-
Moullet, I.1
Salles, G.2
Ketterer, N.3
-
3
-
-
0025315364
-
Decreased erythropoietin response in patients with the anemia of cancer
-
Miller CB, Jones RJ, Piantadosi S, et al. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 1990; 322: 1689-1692.
-
(1990)
N Engl J Med
, vol.322
, pp. 1689-1692
-
-
Miller, C.B.1
Jones, R.J.2
Piantadosi, S.3
-
4
-
-
0026629718
-
Effect of inflammatory cytokines on hypoxia-induced erythropoietin production
-
Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992; 79: 1987-1994.
-
(1992)
Blood
, vol.79
, pp. 1987-1994
-
-
Faquin, W.C.1
Schneider, T.J.2
Goldberg, M.A.3
-
5
-
-
0026569973
-
Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys
-
Jelkmann W, Pagel H, Wolff M, et al. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 1992; 50: 301-308.
-
(1992)
Life Sci
, vol.50
, pp. 301-308
-
-
Jelkmann, W.1
Pagel, H.2
Wolff, M.3
-
6
-
-
84903781218
-
Hemoglobin level influences tumor response and survival after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
-
Hamai Y, Hihara J, Taomoto J, et al. Hemoglobin level influences tumor response and survival after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma. World J Surg 2014; 38: 2046-2051.
-
(2014)
World J Surg
, vol.38
, pp. 2046-2051
-
-
Hamai, Y.1
Hihara, J.2
Taomoto, J.3
-
7
-
-
0034046859
-
Impact of anemia in patients with head and neck cancer
-
Kumar P. Impact of anemia in patients with head and neck cancer. Oncologist 2000; 5: 13-18.
-
(2000)
Oncologist
, vol.5
, pp. 13-18
-
-
Kumar, P.1
-
8
-
-
35448944907
-
The prognostic value of hemoglobin concentration in postoperative radiotherapy of 835 patients with laryngeal cancer
-
Rutkowski T, Suwinski R, Idasiak A. The prognostic value of hemoglobin concentration in postoperative radiotherapy of 835 patients with laryngeal cancer. Int J Radiat Oncol Biol Phys 2007; 69: 1018-1023.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.69
, pp. 1018-1023
-
-
Rutkowski, T.1
Suwinski, R.2
Idasiak, A.3
-
9
-
-
0027444652
-
A predictive model for aggressive non-hodgkin's lymphoma the international non-hodgkin's lymphoma prognostic factors project
-
A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-994.
-
(1993)
N Engl J Med
, vol.329
, pp. 987-994
-
-
-
10
-
-
4444326818
-
Follicular lymphoma international prognostic index
-
Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood 2004; 104: 1258-1265.
-
(2004)
Blood
, vol.104
, pp. 1258-1265
-
-
Solal-Celigny, P.1
Roy, P.2
Colombat, P.3
-
11
-
-
0016804136
-
A clinical staging system for multiple myeloma Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
-
Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975; 36: 842-854.
-
(1975)
Cancer
, vol.36
, pp. 842-854
-
-
Durie, B.G.1
Salmon, S.E.2
-
12
-
-
0017751562
-
A clinical staging system for chronic lymphocytic leukemia: Prognostic significance
-
Binet JL, Lepoprier M, Dighiero G, et al. A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer 1977; 40: 855-864.
-
(1977)
Cancer
, vol.40
, pp. 855-864
-
-
Binet, J.L.1
Lepoprier, M.2
Dighiero, G.3
-
13
-
-
65349135347
-
Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma
-
Li YX, Liu QF, Fang H, et al. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma. Clin Cancer Res 2009; 15: 2905-2912.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 2905-2912
-
-
Li, Y.X.1
Liu, Q.F.2
Fang, H.3
-
14
-
-
84872183512
-
Cyclophosphamide doxorubicin vincristine and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma nasal type: 13-year follow-up in 135 patients
-
Wang L, Xia ZJ, Huang HQ, Lu Y, Zhang YJ. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients. Int J Hematol 2012; 96: 617-623.
-
(2012)
Int J Hematol
, vol.96
, pp. 617-623
-
-
Wang, L.1
Xia, Z.J.2
Huang, H.Q.3
Lu, Y.4
Zhang, Y.J.5
-
15
-
-
84893010631
-
Combination of gemcitabine L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: A retrospective study in a cohort of 227 patients with long-term follow-up
-
Wang L, Wang WD, Xia ZJ, Zhang YJ, Xiang J, Lu Y. Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up. Med Oncol 2014; 31: 860.
-
(2014)
Med Oncol
, vol.31
, pp. 860
-
-
Wang, L.1
Wang, W.D.2
Xia, Z.J.3
Zhang, Y.J.4
Xiang, J.5
Lu, Y.6
-
16
-
-
0031962152
-
Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients
-
Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998; 16: 70-77.
-
(1998)
J Clin Oncol
, vol.16
, pp. 70-77
-
-
Cheung, M.M.1
Chan, J.K.2
Lau, W.H.3
-
17
-
-
0036720257
-
Early stage nasal NK/T-cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality
-
Cheung MM, Chan JK, Lau WH, Ngan RK, Foo WW. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002; 54: 182-190.
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.54
, pp. 182-190
-
-
Cheung, M.M.1
Chan, J.K.2
Lau, W.H.3
Ngan, R.K.4
Foo, W.W.5
-
18
-
-
33644843494
-
Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study
-
Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006; 24: 612-618.
-
(2006)
J Clin Oncol
, vol.24
, pp. 612-618
-
-
Lee, J.1
Suh, C.2
Park, Y.H.3
-
19
-
-
84872087371
-
First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma
-
Wang L, Wang ZH, Chen XQ, et al. First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma. Cancer 2013; 119: 348-355.
-
(2013)
Cancer
, vol.119
, pp. 348-355
-
-
Wang, L.1
Zh, W.2
Chen, X.Q.3
-
20
-
-
79957516735
-
Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: A single-institution experience
-
Huang H, Lin Z, Lin X, Cai Q, Xia Z, Jiang W. Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience. Leuk Lymphoma 2011; 52: 1041-1048.
-
(2011)
Leuk Lymphoma
, vol.52
, pp. 1041-1048
-
-
Huang, H.1
Lin, Z.2
Lin, X.3
Cai, Q.4
Xia, Z.5
Jiang, W.6
-
21
-
-
0042449063
-
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group
-
Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244.
-
(1999)
J Clin Oncol
, vol.17
, pp. 1244
-
-
Cheson, B.D.1
Horning, S.J.2
Coiffier, B.3
-
22
-
-
0020676280
-
Mechanisms of abnormal erythropoiesis in malignancy
-
Dainiak N, Kulkarni V, Howard D, et al. Mechanisms of abnormal erythropoiesis in malignancy. Cancer 1983; 51: 1101-1106.
-
(1983)
Cancer
, vol.51
, pp. 1101-1106
-
-
Dainiak, N.1
Kulkarni, V.2
Howard, D.3
-
23
-
-
84899509396
-
Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma
-
Zhang J, Wang WD, Geng QR, et al. Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma. PLoS One 2014; 9: e94637.
-
(2014)
PLoS One
, vol.9
, pp. e94637
-
-
Zhang, J.1
Wang, W.D.2
Geng, Q.R.3
-
24
-
-
84938055809
-
Increased serum levels of interleukin-15 correlate with negative prognostic factors in extranodal NK/T cell lymphoma
-
Wang H, Zhu JY, Liu CC, et al. Increased serum levels of interleukin-15 correlate with negative prognostic factors in extranodal NK/T cell lymphoma. Med Oncol 2015; 32: 370.
-
(2015)
Med Oncol
, vol.32
, pp. 370
-
-
Wang, H.1
Zhu, J.Y.2
Liu, C.C.3
-
25
-
-
84883704858
-
Clinical significance of serum soluble interleukin-2 receptor-alpha in extranodal natural killer/T-cell lymphoma (ENKTL): A predictive biomarker for treatment efficacy and valuable prognostic factor
-
Wang L, Liao DZ, Zhang J, et al. Clinical significance of serum soluble interleukin-2 receptor-alpha in extranodal natural killer/T-cell lymphoma (ENKTL): a predictive biomarker for treatment efficacy and valuable prognostic factor. Med Oncol 2013; 30: 723.
-
(2013)
Med Oncol
, vol.30
, pp. 723
-
-
Wang, L.1
Liao, D.Z.2
Zhang, J.3
-
26
-
-
0033824339
-
Blood hemoglobin level may affect radiosensitivity-preliminary results on acutely reacting normal tissues
-
Henke M, Bechtold C, Momm F, et al. Blood hemoglobin level may affect radiosensitivity-preliminary results on acutely reacting normal tissues. Int J Radiat Oncol Biol Phys 2000; 48: 339-345.
-
(2000)
Int J Radiat Oncol Biol Phys
, vol.48
, pp. 339-345
-
-
Henke, M.1
Bechtold, C.2
Momm, F.3
-
27
-
-
0032708195
-
Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome
-
Brizel DM, Dodge RK, Clough RW, et al. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 1999; 53: 113-117.
-
(1999)
Radiother Oncol
, vol.53
, pp. 113-117
-
-
Brizel, D.M.1
Dodge, R.K.2
Clough, R.W.3
-
28
-
-
0030854534
-
Evaluation of the concept of hypoxic fraction as a descriptor of tumor oxygenation status
-
Evans SM, Jenkins WT, Shapiro M, et al. Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status. Adv Exp Med Biol 1997; 411: 215-225.
-
(1997)
Adv Exp Med Biol
, vol.411
, pp. 215-225
-
-
Evans, S.M.1
Jenkins, W.T.2
Shapiro, M.3
-
29
-
-
84858707231
-
Radiotherapy alone with curative intent in patients with stage i extranodal nasal-type NK/T-cell lymphoma
-
Li YX, Wang H, Jin J, et al. Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK/T-cell lymphoma. Int J Radiat Oncol Biol Phys 2012; 82: 1809-1815.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.82
, pp. 1809-1815
-
-
Li, Y.X.1
Wang, H.2
Jin, J.3
-
30
-
-
0342905409
-
Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment
-
Kim GE, Cho JH, Yang WI, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 2000; 18: 54-63.
-
(2000)
J Clin Oncol
, vol.18
, pp. 54-63
-
-
Kim, G.E.1
Cho, J.H.2
Yang, W.I.3
-
31
-
-
53549130011
-
Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type
-
Wang B, Li XQ, Ma X, et al. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type. Am J Hematol 2008; 83: 795-799.
-
(2008)
Am J Hematol
, vol.83
, pp. 795-799
-
-
Wang, B.1
Li, X.Q.2
Ma, X.3
-
32
-
-
81755172136
-
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: The NK-Cell Tumor Study Group study
-
Yamaguchi M, Kwong YL, Kim WS, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 2011; 29: 4410-4416.
-
(2011)
J Clin Oncol
, vol.29
, pp. 4410-4416
-
-
Yamaguchi, M.1
Kwong, Y.L.2
Kim, W.S.3
-
33
-
-
79951483189
-
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
-
Jaccard A, Gachard N, Marin B, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood 2011; 117: 1834-1839.
-
(2011)
Blood
, vol.117
, pp. 1834-1839
-
-
Jaccard, A.1
Gachard, N.2
Marin, B.3
-
34
-
-
65449159015
-
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: A study of 136 cases from the International Peripheral T-Cell Lymphoma Project
-
Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009; 113: 3931-3937.
-
(2009)
Blood
, vol.113
, pp. 3931-3937
-
-
Au, W.Y.1
Weisenburger, D.D.2
Intragumtornchai, T.3
-
35
-
-
84919917940
-
Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type
-
Jiang L, Li P, Wang H, et al. Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type. Med Oncol 2014; 31: 218.
-
(2014)
Med Oncol
, vol.31
, pp. 218
-
-
Jiang, L.1
Li, P.2
Wang, H.3
-
36
-
-
84878410620
-
Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type
-
Li YJ, Li ZM, Xia Y, et al. Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type. PLoS One 2013; 8: e64158.
-
(2013)
PLoS One
, vol.8
, pp. e64158
-
-
Li, Y.J.1
Li, Z.M.2
Xia, Y.3
-
37
-
-
84919904805
-
A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type
-
Wang KF, Chang BY, Chen XQ, et al. A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type. Med Oncol 2014; 31: 318.
-
(2014)
Med Oncol
, vol.31
, pp. 318
-
-
Wang, K.F.1
Chang, B.Y.2
Chen, X.Q.3
-
38
-
-
84914098795
-
Targeting the PD-1/PD-L1 immune checkpoint signal-a new treatment strategy for cancer
-
Hamanishi J, Konishi I. [Targeting the PD-1/PD-L1 immune checkpoint signal-a new treatment strategy for cancer]. Gan To Kagaku Ryoho 2014; 41: 1071-1076.
-
(2014)
Gan to Kagaku Ryoho
, vol.41
, pp. 1071-1076
-
-
Hamanishi, J.1
Konishi, I.2
-
39
-
-
84924357098
-
CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type
-
Li P, Jiang L, Zhang X, et al. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type. BMC Cancer 2014; 14: 890.
-
(2014)
BMC Cancer
, vol.14
, pp. 890
-
-
Li, P.1
Jiang, L.2
Zhang, X.3
|